title: The road ahead: working towards effective clinical translation of myocardial gene therapies.
abstract: During the last two decades the fields of molecular and cellular cardiology, and more recently molecular cardiac surgery, have developed rapidly. The concept of delivering cDNA encoding a therapeutic gene to cardiomyocytes using a vector system with substantial cardiac tropism, allowing for long-term expression of a therapeutic protein, has moved from hypothesis to bench to clinical application. However, the clinical results to date are still disappointing. The ideal gene transfer method should be explored in clinically relevant animal models of heart disease to evaluate the relative roles of specific molecular pathways in disease pathogenesis, helping to validate the potential targets for therapeutic intervention. Successful clinical cardiovascular gene therapy also requires the use of nonimmunogenic cardiotropic vectors capable of expressing the requisite amount of therapeutic protein in vivo and in situ. Depending on the desired application either regional or global myocardial gene delivery is required. Cardiac-specific delivery techniques incorporating mapping technologies for regional delivery and highly efficient methodologies for global delivery should improve the precision and specificity of gene transfer to the areas of interest and minimize collateral organ gene expression.
authors.affiliation: 1001 Blythe Blvd, Suite 300, Charlotte, NC 28203, Sanger Heart & Vascular Institute, Carolinas Healthcare System, Charlotte NC, USA.
authors.forename: Michael G
authors.initials: MG
authors.lastname: Katz
authors.forename: Anthony S
authors.initials: AS
authors.lastname: Fargnoli
authors.forename: Richard D
authors.initials: RD
authors.lastname: Williams
authors.forename: Charles R
authors.initials: CR
authors.lastname: Bridges
mesh_terms: D000818:Animals; D009202:Cardiomyopathies / Q000235:genetics / Q000517:prevention & control / Q000628:therapy*; D002986:Clinical Trials as Topic; D016503:Drug Delivery Systems; D018390:Gene Targeting; D018014:Gene Transfer Techniques; D015316:Genetic Therapy / Q000379:methods*; D005822:Genetic Vectors; D006331:Heart Diseases / Q000235:genetics / Q000517:prevention & control / Q000628:therapy*; D006801:Humans; D014780:Viruses / Q000235:genetics